CIC Capital Corporation

CIC Capital Corporation is a specialized subsidiary of the China Investment Corporation (CIC), established in 2015 to manage direct investments and bilateral/multilateral funds. While not a biotechnology or pharmaceutical developer itself, the firm is a significant global investor in the life sciences and healthcare sectors, providing capital for large-scale acquisitions and growth-stage companies. Its mandate includes making long-term investments in infrastructure, energy, and healthcare to support the broader strategic goals of China's sovereign wealth fund. In the healthcare space, CIC Capital has participated in major funding rounds and acquisitions involving global contract research organizations (CROs), genomic technology firms, and healthcare service providers. The corporation operates as a financial powerhouse that facilitates the expansion of established healthcare entities through direct equity participation.